| Year |
Citation |
Score |
| 2018 |
Ganesh VK, Muthuvel SK, Smith SA, Kotwal GJ, Murthy KHM. Retraction of "Structural Basis for Antagonism by Suramin of Heparin Binding to Vaccinia Complement Protein". Biochemistry. PMID 30278609 DOI: 10.1021/Acs.Biochem.8B00955 |
0.339 |
|
| 2018 |
Murthy KH, Smith SA, Ganesh VK, Judge KW, Mullin N, Barlow PN, Ogata CM, Kotwal GJ. Retraction Notice to: Crystal Structure of a Complement Control Protein that Regulates Both Pathways of Complement Activation and Binds Heparan Sulfate Proteoglycans Cell. 175: 1992. DOI: 10.1016/J.Cell.2018.11.047 |
0.34 |
|
| 2014 |
Kotwal GJ, Fernando N, Zhou J, Valter K. Exploring the potential benefits of vaccinia virus complement control protein in controlling complement activation in pathogenesis of the central nervous system diseases. Molecular Immunology. 61: 204-9. PMID 25052409 DOI: 10.1016/J.Molimm.2014.06.022 |
0.307 |
|
| 2012 |
Kotwal GJ, Hatch S, Marshall WL. Viral infection: an evolving insight into the signal transduction pathways responsible for the innate immune response. Advances in Virology. 2012: 131457. PMID 22997518 DOI: 10.1155/2012/131457 |
0.304 |
|
| 2012 |
Kulkarni AP, Govender D, Kellaway LA, Kotwal GJ. Central nervous system distribution of the poxviral proteins after intranasal administration of proteins and titering of vaccinia virus in the brain after intracranial administration. Methods in Molecular Biology (Clifton, N.J.). 890: 305-26. PMID 22688775 DOI: 10.1007/978-1-61779-876-4_18 |
0.445 |
|
| 2012 |
Kulkarni AP, Kellaway LA, Kotwal GJ. Application of quartz crystal microbalance with dissipation monitoring technology for studying interactions of poxviral proteins with their ligands. Methods in Molecular Biology (Clifton, N.J.). 890: 289-303. PMID 22688774 DOI: 10.1007/978-1-61779-876-4_17 |
0.39 |
|
| 2012 |
Rus F, Morlock K, Silverman N, Pham N, Kotwal GJ, Marshall WL. Characterization of poxvirus-encoded proteins that regulate innate immune signaling pathways. Methods in Molecular Biology (Clifton, N.J.). 890: 273-88. PMID 22688773 DOI: 10.1007/978-1-61779-876-4_16 |
0.305 |
|
| 2011 |
Kulkarni AP, Govender DA, Kotwal GJ, Kellaway LA. Modulation of anxiety behavior by intranasally administered Vaccinia virus complement control protein and curcumin in a mouse model of Alzheimer's disease Current Alzheimer Research. 8: 95-113. PMID 21143157 DOI: 10.2174/156720511794604598 |
0.318 |
|
| 2010 |
Kotwal GJ. Influence of glycosylation and oligomerization of vaccinia virus complement control protein on level and pattern of functional activity and immunogenicity. Protein & Cell. 1: 1084-92. PMID 21213103 DOI: 10.1007/S13238-010-0139-2 |
0.437 |
|
| 2010 |
Sundararajan A, Ganapathy R, Huan L, Dunlap JR, Webby RJ, Kotwal GJ, Sangster MY. Influenza virus variation in susceptibility to inactivation by pomegranate polyphenols is determined by envelope glycoproteins. Antiviral Research. 88: 1-9. PMID 20637243 DOI: 10.1016/J.Antiviral.2010.06.014 |
0.338 |
|
| 2010 |
Kulkarni AP, Randall PJ, Murthy K, Kellaway LA, Kotwal GJ. Investigation of interaction of vaccinia virus complement control protein and curcumin with complement components c3 and c3b using quartz crystal microbalance with dissipation monitoring technology. The Open Biochemistry Journal. 4: 9-21. PMID 20224684 DOI: 10.2174/1874091X01004010009 |
0.359 |
|
| 2010 |
Ghebremariam YT, Engelbrecht G, Tyler M, Lotz Z, Govender D, Kotwal GJ, Kahn D. Vaccinia virus complement control protein (VCP) improves kidney structure and function following ischemia/reperfusion injury in rats. The Journal of Surgical Research. 159: 747-54. PMID 19691975 DOI: 10.1016/J.Jss.2009.04.049 |
0.355 |
|
| 2009 |
Thorgersen EB, Pharo A, Haverson K, Axelsen AK, Gaustad P, Kotwal GJ, Sfyroera G, Mollnes TE. Inhibition of complement and CD14 attenuates the Escherichia coli-induced inflammatory response in porcine whole blood. Infection and Immunity. 77: 725-32. PMID 19047409 DOI: 10.1128/Iai.01305-08 |
0.306 |
|
| 2008 |
Mathew A, O'Bryan J, Marshall W, Kotwal GJ, Terajima M, Green S, Rothman AL, Ennis FA. Robust intrapulmonary CD8 T cell responses and protection with an attenuated N1L deleted vaccinia virus. Plos One. 3: e3323. PMID 18830408 DOI: 10.1371/Journal.Pone.0003323 |
0.347 |
|
| 2008 |
Kulkarni AP, Pillay NS, Kellaway LA, Kotwal GJ. Intracranial administration of vaccinia virus complement control protein in Mo/Hu APPswe PS1dE9 transgenic mice at an early age shows enhanced performance at a later age using a cheese board maze test. Biogerontology. 9: 405-20. PMID 18679819 DOI: 10.1007/S10522-008-9161-7 |
0.334 |
|
| 2008 |
Pillay NS, Kellaway LA, Kotwal GJ. Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model. Behavioural Brain Research. 192: 173-7. PMID 18490064 DOI: 10.1016/J.Bbr.2008.03.038 |
0.332 |
|
| 2008 |
Kotwal GJ. Genetic diversity-independent neutralization of pandemic viruses (e.g. HIV), potentially pandemic (e.g. H5N1 strain of influenza) and carcinogenic (e.g. HBV and HCV) viruses and possible agents of bioterrorism (variola) by enveloped virus neutralizing compounds (EVNCs). Vaccine. 26: 3055-8. PMID 18241960 DOI: 10.1016/J.Vaccine.2007.12.008 |
0.308 |
|
| 2008 |
Kaur A, Singh R, Kamboj SS, Singh J, Kotwal GJ. In vitro antiviral activity of Crinum latifolium lectin against poxvirus replication Journal of Biological Sciences. 8: 1236-1240. DOI: 10.3923/Jbs.2008.1236.1240 |
0.325 |
|
| 2008 |
Kahn D, Ghebremariam YT, Engelbrecht G, Tyler M, Lotz Z, Govender D, Kotwal G. Vaccinia Virus Complement Control Protein (Vcp) Improves Kidney Structure And Function Following Ischemia/Reperfusion Injury In Rats: 1817 Transplantation. 86: 601. DOI: 10.1097/01.Tp.0000331002.33106.57 |
0.379 |
|
| 2007 |
Pillay NS, Kellaway LA, Kotwal GJ. Vaccinia virus complement control protein significantly improves sensorimotor function recovery after severe head trauma. Brain Research. 1153: 158-65. PMID 17467672 DOI: 10.1016/J.Brainres.2007.03.056 |
0.36 |
|
| 2007 |
Kaur A, Kamboj SS, Singh J, Singh R, Abrahams M, Kotwal GJ, Saxena AK. Purification of 3 monomeric monocot mannose-binding lectins and their evaluation for antipoxviral activity: potential applications in multiple viral diseases caused by enveloped viruses. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 85: 88-95. PMID 17464348 DOI: 10.1139/O06-185 |
0.315 |
|
| 2007 |
Thorgersen EB, Ghebremariam YT, Thurman JM, Fung M, Nielsen EW, Holers VM, Kotwal GJ, Mollnes TE. Candidate inhibitors of porcine complement. Molecular Immunology. 44: 1827-34. PMID 17109963 DOI: 10.1016/J.Molimm.2006.10.004 |
0.342 |
|
| 2007 |
Thorgersen EB, Ghebremariam YT, Nielsen EW, Kotwal GJ, Mollnes TE. Vaccinia virus complement control protein (VCP) is an efficient inhibitor of porcine complement Molecular Immunology. 44: 250. DOI: 10.1016/J.Molimm.2006.07.242 |
0.393 |
|
| 2007 |
London GM, Kulkarni AP, Kotwal GJ. Structural-function relationship of the monkeypox inhibitor of complement enzyme (MOPICE) homolog of the vaccinia virus complements control protein Molecular Immunology. 44: 209. DOI: 10.1016/J.Molimm.2006.07.146 |
0.365 |
|
| 2007 |
Ghebremariam YT, Kahn D, Engelbrecht G, Tyler M, Lotz Z, Govender D, Kotwal GJ. Humanized recombinant vaccinia virus complement control protein (hrVCP) diminishes kidney damage following ischemia/reperfusion injury rats Molecular Immunology. 44: 176. DOI: 10.1016/J.Molimm.2006.07.071 |
0.388 |
|
| 2006 |
Abdul Ajees A, Gunasekaran K, Volanakis JE, Narayana SV, Kotwal GJ, Murthy HM. The structure of complement C3b provides insights into complement activation and regulation. Nature. 444: 221-5. PMID 17051152 DOI: 10.1038/Nature05258 |
0.358 |
|
| 2006 |
Liszewski MK, Leung MK, Hauhart R, Buller RM, Bertram P, Wang X, Rosengard AM, Kotwal GJ, Atkinson JP. Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation. Journal of Immunology (Baltimore, Md. : 1950). 176: 3725-34. PMID 16517741 DOI: 10.4049/Jimmunol.176.6.3725 |
0.374 |
|
| 2005 |
Pillay NS, Kellaway LA, Kotwal GJ. Administration of vaccinia virus complement control protein shows significant cognitive improvement in a mild injury model. Annals of the New York Academy of Sciences. 1056: 450-61. PMID 16387708 DOI: 10.1196/Annals.1352.021 |
0.365 |
|
| 2005 |
Kulkarni AP, Kellaway LA, Kotwal GJ. Herbal complement inhibitors in the treatment of neuroinflammation: future strategy for neuroprotection. Annals of the New York Academy of Sciences. 1056: 413-29. PMID 16387706 DOI: 10.1196/Annals.1352.020 |
0.361 |
|
| 2005 |
Gomes Pereira NA, Juliano MA, Carmona AK, Sturrock ED, Kotwal GJ. Cloning and expression of a functionally active truncated N-glycosylated KSHV ORF4/KCP/kaposica in the methylotrophic yeast Pichia pastoris. Annals of the New York Academy of Sciences. 1056: 388-404. PMID 16387704 DOI: 10.1196/Annals.1352.019 |
0.406 |
|
| 2005 |
Kotwal GJ, Kaczmarek JN, Leivers S, Ghebremariam YT, Kulkarni AP, Bauer G, De Beer C, Preiser W, Mohamed AR. Anti-HIV, anti-poxvirus, and anti-SARS activity of a nontoxic, acidic plant extract from the Trifollium species Secomet-V/anti-vac suggests that it contains a novel broad-spectrum antiviral. Annals of the New York Academy of Sciences. 1056: 293-302. PMID 16387696 DOI: 10.1196/Annals.1352.014 |
0.327 |
|
| 2005 |
Ghebremariam YT, Smith SA, Anderson JB, Kahn D, Kotwal GJ. Intervention strategies and agents mediating the prevention of xenorejection. Annals of the New York Academy of Sciences. 1056: 123-43. PMID 16387682 DOI: 10.1196/Annals.1352.028 |
0.548 |
|
| 2005 |
Ghebremariam YT, Odunuga OO, Janse K, Kotwal GJ. Humanized recombinant vaccinia virus complement control protein (hrVCP) with three amino acid changes, H98Y, E102K, and E120K creating an additional putative heparin binding site, is 100-fold more active than rVCP in blocking both classical and alternative complement pathways. Annals of the New York Academy of Sciences. 1056: 113-22. PMID 16387681 DOI: 10.1196/Annals.1352.024 |
0.463 |
|
| 2005 |
Kulkarni AP, Ghebremariam YT, Kotwal GJ. Curcumin inhibits the classical and the alternate pathways of complement activation. Annals of the New York Academy of Sciences. 1056: 100-12. PMID 16387680 DOI: 10.1196/Annals.1352.007 |
0.333 |
|
| 2005 |
Abrahams MR, Zhang Z, Chien S, Skerns T, Kotwal GJ. The vaccinia virus N1L ORF may encode a multifunctional protein possibly targeting different kinases, one of which influences ATP levels in vivo. Annals of the New York Academy of Sciences. 1056: 87-99. PMID 16387679 DOI: 10.1196/Annals.1352.006 |
0.615 |
|
| 2005 |
Zhang Z, Abrahams MR, Hunt LA, Suttles J, Marshall W, Lahiri DK, Kotwal GJ. The vaccinia virus N1L protein influences cytokine secretion in vitro after infection. Annals of the New York Academy of Sciences. 1056: 69-86. PMID 16387678 DOI: 10.1196/Annals.1352.005 |
0.597 |
|
| 2005 |
Jha P, Smith SA, Justus DE, Kotwal GJ. Vaccinia virus complement control protein ameliorates collagen-induced arthritic mice. Annals of the New York Academy of Sciences. 1056: 55-68. PMID 16387677 DOI: 10.1196/Annals.1352.004 |
0.556 |
|
| 2005 |
Thorbjornsdottir P, Kolka R, Gunnarsson E, Bambir SH, Thorgeirsson G, Kotwal GJ, Arason GJ. Vaccinia virus complement control protein diminishes formation of atherosclerotic lesions: complement is centrally involved in atherosclerotic disease. Annals of the New York Academy of Sciences. 1056: 1-15. PMID 16387673 DOI: 10.1196/Annals.1352.001 |
0.309 |
|
| 2005 |
Ganesh VK, Muthuvel SK, Smith SA, Kotwal GJ, Murthy KH. Structural basis for antagonism by suramin of heparin binding to vaccinia complement protein. Biochemistry. 44: 10757-65. PMID 16086578 DOI: 10.1021/Bi050401X |
0.36 |
|
| 2004 |
Pillay NS, Kellaway LA, Kotwal GJ. Molecular mechanisms, emerging etiological insights and models to test potential therapeutic interventions in Alzheimer's disease. Current Alzheimer Research. 1: 295-306. PMID 15975058 DOI: 10.2174/1567205043331965 |
0.336 |
|
| 2004 |
Reynolds DN, Smith SA, Zhang YP, Mengsheng Q, Lahiri DK, Morassutti DJ, Shields CB, Kotwal GJ. Vaccinia virus complement control protein reduces inflammation and improves spinal cord integrity following spinal cord injury. Annals of the New York Academy of Sciences. 1035: 165-78. PMID 15681807 DOI: 10.1196/Annals.1332.011 |
0.319 |
|
| 2004 |
Kulkarni AP, Kellaway LA, Lahiri DK, Kotwal GJ. Neuroprotection from complement-mediated inflammatory damage. Annals of the New York Academy of Sciences. 1035: 147-64. PMID 15681806 DOI: 10.1196/Annals.1332.010 |
0.352 |
|
| 2004 |
Billings B, Smith SA, Zhang Z, Lahiri DK, Kotwal GJ. Lack of N1L gene expression results in a significant decrease of vaccinia virus replication in mouse brain. Annals of the New York Academy of Sciences. 1030: 297-302. PMID 15659810 DOI: 10.1196/Annals.1329.037 |
0.607 |
|
| 2004 |
DiPerna G, Stack J, Bowie AG, Boyd A, Kotwal G, Zhang Z, Arvikar S, Latz E, Fitzgerald KA, Marshall WL. Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors. The Journal of Biological Chemistry. 279: 36570-8. PMID 15215253 DOI: 10.1074/Jbc.M400567200 |
0.546 |
|
| 2004 |
Ganesh VK, Smith SA, Kotwal GJ, Murthy KH. Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation. Proceedings of the National Academy of Sciences of the United States of America. 101: 8924-9. PMID 15178763 DOI: 10.1073/Pnas.0400744101 |
0.384 |
|
| 2004 |
Kotwal GJ, Abrahams MR. Growing poxviruses and determining virus titer. Methods in Molecular Biology (Clifton, N.J.). 269: 101-12. PMID 15114010 DOI: 10.1385/1-59259-789-0:101 |
0.327 |
|
| 2003 |
Reynolds DN, Smith SA, Zhang YP, Lahiri DK, Morassutti DJ, Shields CB, Kotwal GJ. Vaccinia Virus Complement Control Protein Modulates Inflammation Following Spinal Cord Injury Annals of the New York Academy of Sciences. 1010: 534-539. PMID 15033786 DOI: 10.1196/Annals.1299.099 |
0.396 |
|
| 2003 |
Scott MJ, Burch PT, Jha P, Peyton JC, Kotwal GJ, Cheadle WG. Vaccinia virus complement control protein increases early bacterial clearance during experimental peritonitis. Surgical Infections. 4: 317-26. PMID 15012858 DOI: 10.1089/109629603322761373 |
0.589 |
|
| 2003 |
Jha P, Smith SA, Justus DE, Kotwal GJ. Prolonged retention of vaccinia virus complement control protein following IP injection: implications in blocking xenorejection. Transplantation Proceedings. 35: 3160-2. PMID 14698003 DOI: 10.1016/j.transproceed.2003.10.045 |
0.565 |
|
| 2003 |
Smith SA, Sreenivasan R, Krishnasamy G, Judge KW, Murthy KH, Arjunwadkar SJ, Pugh DR, Kotwal GJ. Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance. Biochimica Et Biophysica Acta. 1650: 30-9. PMID 12922167 DOI: 10.1016/S1570-9639(03)00189-4 |
0.386 |
|
| 2003 |
Kahn D, Smith SA, Kotwal GJ. Dose-dependent inhibition of complement in baboons by vaccinia virus complement control protein: Implications in xenotransplantation Transplantation Proceedings. 35: 1606-1608. PMID 12826233 DOI: 10.1016/S0041-1345(03)00485-8 |
0.431 |
|
| 2003 |
Anderson JB, Smith SA, van Wijk R, Chien S, Kotwal GJ. Vaccinia virus complement control protein inhibits hyperacute xenorejection in a guinea pig-to-rat heterotopic cervical cardiac xenograft model by blocking both xenoantibody binding and complement pathway activation. Transplant Immunology. 11: 129-35. PMID 12799195 DOI: 10.1016/S0966-3274(02)00149-1 |
0.589 |
|
| 2003 |
Jha P, Kotwal GJ. Vaccinia complement control protein: multi-functional protein and a potential wonder drug. Journal of Biosciences. 28: 265-71. PMID 12734405 DOI: 10.1007/Bf02970146 |
0.612 |
|
| 2002 |
Anderson JB, Smith SA, van Wijk R, Chien S, Kotwal GJ. Vaccinia virus complement control protein ameliorates hyperacute xenorejection by inhibiting xenoantibody binding. Transplantation Proceedings. 34: 3277-81. PMID 12493445 DOI: 10.1016/S0041-1345(02)03692-8 |
0.599 |
|
| 2002 |
Kotwal GJ, Lahiri DK, Hicks R. Potential intervention by vaccinia virus complement control protein of the signals contributing to the progression of central nervous system injury to Alzheimer's disease Annals of the New York Academy of Sciences. 973: 317-322. PMID 12485887 DOI: 10.1111/J.1749-6632.2002.Tb04659.X |
0.428 |
|
| 2002 |
Smith SA, Kotwal GJ. Immune response to poxvirus infections in various animals. Critical Reviews in Microbiology. 28: 149-85. PMID 12385498 DOI: 10.1080/1040-840291046722 |
0.335 |
|
| 2002 |
Hicks RR, Keeling KL, Yang MY, Smith SA, Simons AM, Kotwal GJ. Vaccinia virus complement control protein enhances functional recovery after traumatic brain injury. Journal of Neurotrauma. 19: 705-14. PMID 12165132 DOI: 10.1089/08977150260139093 |
0.747 |
|
| 2002 |
Smith SA, Krishnasamy G, Murthy KH, Cooper A, Bromek K, Barlow PN, Kotwal GJ. Vaccinia virus complement control protein is monomeric, and retains structural and functional integrity after exposure to adverse conditions. Biochimica Et Biophysica Acta. 1598: 55-64. PMID 12147344 DOI: 10.1016/S0167-4838(02)00339-4 |
0.355 |
|
| 2002 |
Anderson JB, Smith SA, Kotwal GJ. Vaccinia virus complement control protein inhibits hyperacute xenorejection. Transplantation Proceedings. 34: 1083-5. PMID 12072283 DOI: 10.1016/S0041-1345(02)02805-1 |
0.575 |
|
| 2001 |
Smith SA, Kotwal GJ. Virokines novel immunomodulatory agents Expert Opinion On Biological Therapy. 1: 343-357. PMID 11727510 DOI: 10.1517/14712598.1.3.343 |
0.387 |
|
| 2001 |
Al-Mohanna F, Parhar R, Kotwal GJ. Vaccinia virus complement control protein is capable of protecting xenoendothelial cells from antibody binding and killing by human complement and cytotoxic cells Transplantation. 71: 796-801. PMID 11330545 DOI: 10.1097/00007890-200103270-00019 |
0.411 |
|
| 2001 |
Murthy KHM, Smith SA, Ganesh VK, Judge KW, Mullin N, Barlow PN, Ogata CM, Kotwal GJ. Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans Cell. 104: 301-311. PMID 11207370 DOI: 10.1016/S0092-8674(01)00214-8 |
0.399 |
|
| 2000 |
Smith SA, Mullin NP, Parkinson J, Shchelkunov SN, Totmenin AV, Loparev VN, Srisatjaluk R, Reynolds DN, Keeling KL, Justus DE, Barlow PN, Kotwal GJ. Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense. Journal of Virology. 74: 5659-66. PMID 10823874 DOI: 10.1128/Jvi.74.12.5659-5666.2000 |
0.736 |
|
| 2000 |
Jonczy EA, Daly J, Kotwal GJ. A novel approach using an attenuated recombinant vaccinia virus to test the antipoxviral effects of handsoaps Antiviral Research. 45: 149-153. PMID 10809023 DOI: 10.1016/S0166-3542(00)00067-X |
0.376 |
|
| 2000 |
Kotwal GJ. Poxviral mimicry of complement and chemokine system components: What's the end game? Immunology Today. 21: 242-248. PMID 10782056 DOI: 10.1016/S0167-5699(00)01606-6 |
0.387 |
|
| 2000 |
Keeling KL, Hicks RR, Mahesh J, Billings BB, Kotwal GJ. Local neutrophil influx following lateral fluid-percussion brain injury in rats is associated with accumulation of complement activation fragments of the third component (C3) of the complement system. Journal of Neuroimmunology. 105: 20-30. PMID 10713360 DOI: 10.1016/S0165-5728(00)00183-1 |
0.729 |
|
| 2000 |
Kotwal GJ, Lahiri DK. Regulation of Aβ-mediated complement activation by vaccinia virus complement control protein Neurobiology of Aging. 21: 128. DOI: 10.1016/S0197-4580(00)82375-1 |
0.416 |
|
| 1999 |
Daly J, Lahiri DK, Kotwal GJ. Examination of the interactions of the amyloid precursor protein carboxyl terminus to intracellular protein: Possible role in apoptosis Progress in Neuro-Psychopharmacology and Biological Psychiatry. 23: 861-875. PMID 10509380 DOI: 10.1016/S0278-5846(99)00046-9 |
0.328 |
|
| 1998 |
Daly IV J, Kotwal GJ. Pro-inflammatory complement activation by the Aβ peptide of Alzheimer's disease is biologically significant and can be blocked by vaccinia virus complement control protein Neurobiology of Aging. 19: 619-627. PMID 10192224 DOI: 10.1016/S0197-4580(98)00100-6 |
0.35 |
|
| 1998 |
Daly J, Lahiri DK, Justus DE, Kotwal GJ. Detection of the membrane-retained carboxy-terminal tail containing polypeptides of the amyloid precursor protein in tissue from Alzheimer's disease brain. Life Sciences. 63: 2121-31. PMID 9839536 DOI: 10.1016/S0024-3205(99)80009-5 |
0.318 |
|
| 1998 |
Kotwal GJ, Miller CG, Justus DE. The inflammation modulatory protein (IMP) of cowpox virus drastically diminishes the tissue damage by down-regulating cellular infiltration resulting from complement activation. Molecular and Cellular Biochemistry. 185: 39-46. PMID 9746210 DOI: 10.1023/A:1006844624825 |
0.4 |
|
| 1998 |
Howard J, Justus DE, Totmenin AV, Shchelkunov S, Kotwal GJ. Molecular mimicry of the inflammation modulatory proteins (IMPs) of poxviruses: evasion of the inflammatory response to preserve viral habitat. Journal of Leukocyte Biology. 64: 68-71. PMID 9665277 DOI: 10.1002/Jlb.64.1.68 |
0.375 |
|
| 1998 |
Keeling K, Mahesh J, Hicks R, Kotwal G. Study of the role of complement in contributing to neutrophil influx in models for multiple organ dysfunction syndrome (MODS) Molecular Immunology. 35: 365. DOI: 10.1016/S0161-5890(98)90669-1 |
0.706 |
|
| 1997 |
Miller CG, Shchelkunov SN, Kotwal GJ. The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein Virology. 229: 126-133. PMID 9123854 DOI: 10.1006/Viro.1996.8396 |
0.416 |
|
| 1997 |
Miller CG, Justus DE, Kotwal GJ. COWPOX VIRUS IMP MODULATES THE INFLAMMATORY RESPONSE BY RESTRICTING MONONUCLEAR CELL INFILTRATION Shock. 7: 74. DOI: 10.1097/00024382-199703001-00296 |
0.321 |
|
| 1995 |
Miller CG, Justus DE, Jayaraman S, Kotwal GJ. Severe and prolonged inflammatory response to localized cowpox virus infection in footpads of C5-deficient mice: investigation of the role of host complement in poxvirus pathogenesis. Cellular Immunology. 162: 326-32. PMID 7743560 DOI: 10.1006/Cimm.1995.1086 |
0.404 |
|
| 1992 |
Isaacs SN, Kotwal GJ, Moss B. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence Proceedings of the National Academy of Sciences of the United States of America. 89: 628-632. PMID 1731333 DOI: 10.1073/Pnas.89.2.628 |
0.406 |
|
| 1992 |
McKenzie R, Kotwal GJ, Moss B, Hammer CH, Frank MM. Regulation of complement activity by vaccinia virus complement-control protein. The Journal of Infectious Diseases. 166: 1245-50. PMID 1431243 DOI: 10.1093/Infdis/166.6.1245 |
0.335 |
|
| 1990 |
Kotwal GJ, Isaacs SN, McKenzie R, Frank MM, Moss B. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science (New York, N.Y.). 250: 827-30. PMID 2237434 DOI: 10.1126/Science.2237434 |
0.34 |
|
| 1983 |
Kotwal GJ, Capone J, Irving RA, Rhee SH, Bilan P, Toneguzzo F, Hofmann T, Ghosh HP. Viral membrane glycoproteins: Comparison of the amino acid terminal amino acid sequences of the precursor and mature glycoproteins of three serotypes of vesicular stomatitis virus Virology. 129: 1-11. PMID 6310873 DOI: 10.1016/0042-6822(83)90390-2 |
0.606 |
|
| 1982 |
Bergeron JJ, Kotwal GJ, Levine G, Bilan P, Rachubinski R, Hamilton M, Shore GC, Ghosh HP. Intracellular transport of the transmembrane glycoprotein G of vesicular stomatitis virus through the Golgi apparatus as visualized by electron microscope radioautography. The Journal of Cell Biology. 94: 36-41. PMID 6288738 DOI: 10.1083/Jcb.94.1.36 |
0.617 |
|
| Show low-probability matches. |
